ScienceMedia, Inc. (SMi) Company Profile

Background

Overview

ScienceMedia, Inc. (SMi) is a San Diego-based company specializing in delivering innovative, multimedia learning solutions aimed at enhancing clinical competency within the life sciences sector. Established in 1993, SMi has been at the forefront of creating engaging and scientifically validated training programs for pharmaceutical companies, contract research organizations (CROs), and other stakeholders in the healthcare industry.

Mission and Vision

SMi's mission is to improve on-the-job clinical competency by teaching complex science in easier ways to life sciences-focused organizations. Their vision is to revolutionize clinical training by providing scientifically validated, engaging, and interactive educational content that accelerates clinical trial timelines and enhances overall study outcomes.

Primary Area of Focus

The company focuses on developing multimedia educational content that addresses the highest risk areas of clinical trials, aiming to mitigate clinical risks and decrease trial costs by optimizing study compliance throughout the trial lifecycle.

Industry Significance

SMi holds a significant position in the life sciences education sector, providing over 16,000 microlearning topics and 400+ full courses covering a vast catalog of disease and therapeutic areas. Their solutions are utilized by major life science companies to enhance clinical competency across various functional areas.

Key Strategic Focus

Core Objectives

• Enhance clinical trial efficiency by reducing timelines by up to 20%.

• Accelerate site activations, often by months.

• Save $1-2 million in R&D spend per trial.

Specific Areas of Specialization

• Protocol compliance training for site staff and study teams.

• Customized video training for participants to boost enrollment, engagement, and retention.

• Comprehensive educational content covering a wide range of therapeutic areas.

Key Technologies Utilized

• MindFlow™ methodology, a science of learning approach.

• Mobile-enabled, cloud-based platforms for content delivery.

• Interactive multimedia formats, including video, animations, and assessments.

Primary Markets Targeted

• Biopharmaceutical companies.

• Contract research organizations (CROs).

• Medical device companies.

• Healthcare providers involved in clinical trials.

Financials and Funding

Funding History

SMi has undergone multiple funding rounds, including a Series B round, to support its growth and innovation initiatives. Specific details regarding the total funds raised and notable investors are not publicly disclosed.

Utilization of Capital

The capital raised has been utilized to:

• Develop and enhance educational content and platforms.

• Expand the company's product offerings.

• Strengthen partnerships and collaborations within the industry.

Pipeline Development

Key Pipeline Candidates

SMi offers a comprehensive suite of training solutions, including:

• SMi Trial: Protocol compliance and risk-based study training.

• SMi Engage: Customized video training for participants to boost enrollment, engagement, and retention.

• SMi Source: A mobile-enabled, cloud-based science education library with over 16,000 microlearning topics and 400+ full courses.

Stages of Development

These platforms are fully developed and actively utilized by clients in the life sciences sector.

Target Conditions

The training content covers a vast array of disease and therapeutic areas, including:

• Cardiovascular

• Dermatology

• Drug Development

• Endocrinology

• Gastroenterology

• Genetics

• Hematology

• Immunology

• Infectious Disease

• Men's and Women's Health

• Musculoskeletal

• Nephrology

• Neurology

• Ophthalmology

• Physiology

• Rare Diseases

Anticipated Milestones

SMi continues to expand its content library and enhance platform functionalities to meet the evolving needs of the life sciences industry.

Technological Platform and Innovation

Proprietary Technologies

• MindFlow™ Methodology: A science of learning approach that integrates cognitive science principles to enhance knowledge retention and application.

Significant Scientific Methods

• Utilization of cognitive and adult learning theories to design engaging and effective training programs.

• Incorporation of interactive multimedia elements to cater to diverse learning styles.

AI-Driven Capabilities

• While specific AI-driven capabilities are not detailed, SMi's platforms leverage advanced technologies to deliver personalized and adaptive learning experiences.

Leadership Team

Key Executives

• Mark Surles, Ph.D.: Chief Executive Officer.

• Margaret Harmon, Ph.D.: Director, Content.

• Michael Komai: Director, Systems Integration.

• Rory Mauro, M.P.H.: Director, Client Services.

• Philip Bedrin: Vice President, Medical & Clinical Solutions.

• Malachi Bierstein: Chief Commercial Officer.

Professional Backgrounds and Contributions

• Mark Surles, Ph.D.: With over 20 years of experience leading software and content companies in the life science market, Mark was the founder and CEO of Interactive Simulations and has held executive roles at Elsevier. He holds a Ph.D. in Computer Science from the University of North Carolina at Chapel Hill.

• Margaret Harmon, Ph.D.: Margaret leads curriculum design and medical writing at ScienceMedia. She has extensive teaching experience and was awarded the Distinguished Teaching Award at UCLA. She holds a Ph.D. in Biology with an emphasis on Molecular Endocrinology from UCLA.

• Michael Komai: Michael leads development across ScienceMedia's product platforms. He has 11 years of research experience in molecular biology and pharmaceutical sciences and 17 years in the education and entertainment industries.

• Rory Mauro, M.P.H.: Rory is the Director of Client Services at ScienceMedia, leading opportunity management and contracting. He has 10 years of experience coordinating and project managing life science multimedia training deliverables.

• Philip Bedrin: With over 15 years of experience in the Life Sciences space, Philip has led various strategic and global initiatives in the healthcare and biopharmaceutical industries. He holds a B.S. in Business Administration from Rider University.

• Malachi Bierstein: Malachi leads global sales and marketing and is responsible for driving the commercial growth of the company. He has held senior leadership positions at Nokia Technologies, Rovi, and DivX. He holds a B.S. in Industrial and Systems Engineering from the University of Florida.

Leadership Changes

No recent significant changes or appointments within the company's leadership have been publicly disclosed.

Competitor Profile

Market Insights and Dynamics

The life sciences education and training market is experiencing significant growth, driven by the increasing complexity of clinical trials and the need for efficient, scalable training solutions. Companies are seeking innovative approaches to enhance clinical competency and accelerate trial timelines.

Competitor Analysis

• Medable: Focuses on decentralized clinical trials, offering a platform that enables remote patient monitoring and data collection.

• Elemeno Health: Provides a mobile-based platform for frontline healthcare workers, delivering real-time, evidence-based guidance and training.

• Ryght AI: Utilizes artificial intelligence to optimize clinical trial design and patient recruitment processes.

Strategic Collaborations and Partnerships

SMi has established partnerships to enhance its offerings:

• ACTO: An AI-powered Intelligent Field Excellence platform for life sciences, collaborating with SMi to empower field teams.

Operational Insights

SMi differentiates itself through its comprehensive content library, scientifically validated training programs, and the MindFlow™ methodology, setting it apart from competitors in the market.